Investing Profile

Jeremy Caldwell

InvestorVC
Partner, Red Tree Venture Capital at Red Tree Venture Capital
Photo of Jeremy Caldwell, Partner at Red Tree Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
760 CONNECTIONS
Stanford University Network
510 CONNECTIONS
Merck Network
62 CONNECTIONS
Third Rock Ventures Network
54 CONNECTIONS
Stanford University School of Medicine Network
46 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
CompanyStageDateRound SizeTotal Raised
Lycia Therapeutics
Series BSep 2021$70M
$200M
Co-investors: Roderick Wong (RTW Investments, LP), Clare Ozawa (Versant Ventures)
Graduate Student Stanford UniversityPresent
Project Leader Rigel Pharmaceuticals Inc.Present
Executive Director, Molecular and Cell Biology, Lead Discovery and Genomics GNFPresent
Vice President, RNA Therapeutics, Screening and Protein Sciences MerckPresent
Entrepreneur in Residence Third Rock VenturesPresent
Executive Vice President and Chief Scientific Officer Ardelyx, Inc.Present
Board of Directors Zond LLCPresent
Board of Directors Chinook Therapeutics, Inc.Present
Board of Directors ADAXION TherapeuticsPresent
Board of Directors Lycia TherapeuticsPresent
Board of Directors Belharra TherapeuticsPresent
Chairman of the Board BioGraph 55Present
Board Member Sardona TherapeuticsPresent
Board of Directors EBVioPresent
Managing Director Red Tree Venture CapitalPresent
President and Chief Executive Officer Zond LLCPresent
President and Chief Executive Officer Mistral TherapeuticsPresent
President and Chief Executive Officer Inception TherapeuticsPresent
Venture Partner Versant VenturesPresent
Co-Founder Light Horse TherapeuticsPresent
Partner, Red Tree Venture Capital Red Tree Venture CapitalPresent
University of California, Berkeley BA Molecular and Cell Biology
Stanford University School of Medicine PhD Molecular Pharmacology
Sign in with Google →
Sign in with Google →